Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

ThermaCare sale a wrap

This article was originally published in The Tan Sheet

Executive Summary

Wyeth Consumer Healthcare owns the heat wrap ThermaCare after closing the acquisition for an undisclosed amount from Procter & Gamble Sept. 2. Wyeth previously said it sees "tremendous synergy between ThermaCare and Advil," and "significant growth potential" in the heat wrap (1"The Tan Sheet" July 21, 2008, p. 8)

You may also be interested in...



Chattem Launching ACT, Icy Hot Line Extensions, Raises Guidance

Chattem says planned launches of line extensions for ACT,Icy Hot and other products in part prompted it to set its fiscal 2009 guidance at 60 cents to 75 cents per share above its 2008 guidance

Top-Selling ThermaCare Heats Up Wyeth’s Pain-Management Synergy Plans

Wyeth Consumer Healthcare will expand its OTC pain management line by buying category-leading heat wrapThermaCare from Procter & Gamble for an undisclosed amount

Biogen’s Big Day Arrives, But Aducanumab Results Don’t Answer Key Question

Biogen presented highly anticipated data in Alzheimer’s disease at CTAD for its Phase III EMERGE and ENGAGE studies, but one major question remains unanswered: will the FDA approve the drug? 

Topics

UsernamePublicRestriction

Register

PS102085

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel